Reassortment and Mutations Associated with Emergence and Spread of Oseltamivir-Resistant Seasonal Influenza A/H1N1 Viruses in 2005–2009 by Yang, Ji-Rong et al.
Reassortment and Mutations Associated with Emergence
and Spread of Oseltamivir-Resistant Seasonal Influenza
A/H1N1 Viruses in 2005–2009
Ji-Rong Yang
1, Yu-Cheng Lin
1, Yuan-Pin Huang
1, Chun-Hui Su
1,J eL o
1, Yu-Lin Ho
1, Ching-Yuan Yao
1,
Li-Ching Hsu
1, Ho-Sheng Wu
1,2*, Ming-Tsan Liu
1*
1Research and Diagnostic Center, Centers for Disease Control, Taipei, Taiwan, Republic of China, 2School of Medical Laboratory Science and Biotechnology, Taipei
Medical University, Taipei, Taiwan, Republic of China
Abstract
A dramatic increase in the frequency of the H275Y mutation in the neuraminidase (NA), conferring resistance to oseltamivir,
has been detected in human seasonal influenza A/H1N1 viruses since the influenza season of 2007–2008. The resistant
viruses emerged in the ratio of 14.3% and quickly reached 100% in Taiwan from September to December 2008. To explore
the mechanisms responsible for emergence and spread of the resistant viruses, we analyzed the complete genome
sequences of 25 viruses collected during 2005–2009 in Taiwan, which were chosen from various clade viruses, 1, 2A, 2B-1,
2B-2, 2C-1 and 2C-2 by the classification of hemagglutinin (HA) sequences. Our data revealed that the dominant variant,
clade 2B-1, in the 2007–2008 influenza emerged through an intra-subtype 4+4 reassortment between clade 1 and 2 viruses.
The dominant variant acquired additional substitutions, including A206T in HA, H275Y and D354G in NA, L30R and H41P in
PB1-F2, and V411I and P453S in basic polymerase 2 (PB2) proteins and subsequently caused the 2008–2009 influenza
epidemic in Taiwan, accompanying the widespread oseltamivir-resistant viruses. We also characterized another 3+5
reassortant virus which became double resistant to oseltamivir and amantadine. Comparison of oseltamivir-resistant
influenza A/H1N1 viruses belonging to various clades in our study highlighted that both reassortment and mutations were
associated with emergence and spread of these viruses and the specific mutation, H275Y, conferring to antiviral resistance,
was acquired in a hitch-hiking mechanism during the viral evolutionary processes.
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Introduction
Influenza viruses cause annual epidemics in many countries and
occasional worldwide pandemics. Influenza vaccine and antiviral
drugs are two useful measures for preventing influenza and
reducing the impact of epidemics. Currently, there have been two
classes of antiviral drugs available for preventing and treating
influenza illness: M2 ion channel blockers, adamantanes (aman-
tadine and rimantadine), and neuraminidase inhibitors (oseltami-
vir, zanamivir and peramivir). Since the 2005–2006 influenza
season, most human influenza A/H3N2 viruses circulating
worldwide were found to carry S31N in the M2 protein,
conferring to adamantane-resistance [1,2]. In the season of
2007–2008, oseltamivir-resistant seasonal influenza A/H1N1
viruses carrying H275Y (N1 numbering) in the NA protein were
detected in Europe and spread globally in the absence of drug
selective pressure [3,4,5]. At the end of the 2007–2008 season, the
mean percentage of oseltamivir-resistant isolates was 25% in
Europe, 12.3% in USA, 26% in Canada, 12% in Hong Kong and
3% in Japan [6,7,8,9]. By the season of 2008–2009, most of the
seasonal influenza A/H1N1 viruses have been resistant to
oseltamivir [9]. Emergence and spread of antiviral-resistant viruses
pose a challenge regarding the strategies for treating and
preventing influenza.
There are three key factors affecting the evolutionary processes
of antiviral resistant influenza viruses from their original
appearance to worldwide spread. The first factor is the frequency
of drug resistant mutants arising de novo during treatment, the
second is the ability to overcome the obstacle of viral fitness caused
by resistant mutations [10] and the last is to replace existing strains
by reassortment and/or drift mutations. Based on the example of
adamantane-resistant influenza A/H3N2 viruses, these viruses
have been reported to occur de novo at a high frequency in about
27–33% of treated patients [11,12] and these remained patho-
genic and transmissible, compared to wild-type viruses [13]. The
adamantane-resistant A/H3N2 viruses circulating worldwide in
2005–2006 were reported to be generated through reassortment
and additional substitutions [14]. In the example of oseltamivir-
resistant seasonal influenza A/H1N1 viruses, the frequency of
drug resistant viruses appearing during clinical trials was from 0.3
to 18% [15,16,17]. Before 2006, oseltamivir-resistant seasonal A/
H1N1 viruses were found to be compromised for replication and
transmission in vitro and in vivo, compared to the corresponding
wild-type [18,19]. In the 2007–2008 influenza season, oseltamivir-
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e18177resistant influenza A/H1N1 viruses likely adapted to the human
population, became predominant and circulated globally. In
particular, the viruses did not differ epidemiologically or clinically
from susceptible isolates [3,5,20,21,22,23]. Therefore, it is an
important issue for understanding evolution of antiviral viruses
that genetic change(s) may lead to optimization of viral fitness and
enable a compromised virus to become predominant and spread
globally.
In this study, we determined the frequency of the H275Y
mutation in the NA to survey the oseltmivir-resistant seasonal
influenza A/H1N1 viruses in Taiwan and found that a sudden and
dramatic increase in the frequency of the H275Y mutation has
been detected since September, 2008. Therefore, we combined the
data of influenza epidemic surveillance as well as oseltamivir-
resistance testing and complete genetic analysis of the circulating
viruses during 2005–2009 to investigate the mechanisms respon-
sible for emergence and spread of these resistant viruses in
Taiwan.
Results
Increase of oseltamivir-resistant seasonal influenza
A/H1N1 viruses in Taiwan from September 2008
From January 2005 to August 2008, a total of 47 seasonal
influenza A/H1N1 viruses in Taiwan were tested for the presence
of H275Y substitution in the NA and only two (4.2%) isolates, A/
Taiwan/0045/2006 and A/Taiwan/3293/2008, were shown to
be positive for this substitution. However, the frequency of viruses
harboring H275Y started to increase from September 2008 (2/14,
14.3%) and quickly reached 100% (37/37) in December (Fig. 1A).
Because the seasonal influenza A/H1N1 viruses were the
predominant subtype in the two successive influenza seasons of
2007–2008 and 2008–2009 in Taiwan (Fig. 1B), it was striking that
the oseltamivir-resistant influenza A/H1N1 viruses emerged and
spread quickly in the second (2008–2009) epidemic season.
Variant evolution of seasonal influenza A/H1N1 viruses
associated with the spread of oseltamivir resistance
From 2005 to 2009, three influenza epidemics in 2005–2006,
2007–2008 and 2008–2009 in Taiwan were caused predominantly
by seasonal influenza A/H1N1 viruses (Fig. 1B). Among the total
of 1660 viruses isolated during this period, we determined the
partial HA sequences (HA1 domain) of the 1585 viruses. The
epidemiological curves regarding various HA clade viruses were
plotted in Fig. 1C. In Taiwan, the epidemic of 2005–2006 was
dominated by clade 2A viruses, accompanied by clade 1 and 2C-1
viruses as minor variants. In addition, the clade 2C-1 viruses,
which were first identified in May 2006, continued to circulate at
low levels in the following years (Fig. 1C). The viruses of clade 2B-
1 were first detected in April 2007 in Taiwan and peaked in
January 2008, followed by transient replacement by clade 2C-2
viruses in September 2008. Another replacement occurred with
viruses of clade 2B-2, which were first detected in September 2008
and quickly became the predominant strains from December 2008
(Fig. 1C).
To investigate the relationship between variant evolution and
emergence of the oseltamivir-resistant viruses, we determined the
prevalence of the H275Y substitution in various clade viruses in
Taiwan. Of the HA clade 1 and 2A viruses, none was found to
carry H275Y substitution (0/5 and 0/9, respectively; Table 1).
Regarding the clade 2B viruses, 8 out of 34 (23.5%) clade 2B-1
viruses and all of the 130 clade 2B-2 viruses were positive for
H275Y (Table 1). Among the 22 clade 2C viruses, there was only
one belonging to clade 2C-2 detected with the H275Y (1/22,
4.5%, Table 1). Based on these comparisons, the high prevalence
of oseltamivir-resistant seasonal influenza A/H1N1 viruses during
2008–2009 in Taiwan was mostly caused by viruses of clade 2B-2.
This indicated that the emergence and predominance of this new
variant was accompanied by the spread of oseltamivir resistance.
Complete sequence analysis of the seasonal influenza A/
H1N1 viruses
Twenty five representative viruses isolated during 2005–2009 in
Taiwan, which were selected from different HA clade viruses
(Table 2), plus three early oseltamivir-resistant influenza A/H1N1
viruses from other countries, A/England/494/2006, A/England/
594/2006 and A/Kansas/UR06-0104/2007, and two vaccine
strains A/New Caledonia/20/1999 and A/Brisbane/59/2007
were performed for complete sequence analysis (the last five were
obtained from the NCBI database), and the phylogenetic
topologies of each of the genome segments were determined.
The phylogenetic topologies of HA, NA, PB2 and PA genes were
similar. In the HA and NA trees, clade 2B viruses were more
closely related to clade 2C than 2A (Fig. 2A and Fig. S1). In the
PB2 and PA genes, clade 2A viruses were grouped with 2C rather
than 2B (Fig. 2B and Fig. S1). In contrast, the phylogenetic
analysis of PB1, NP, NS and M genes revealed that the clade-2B
viruses classified by HA genes were shifted to clade 1(Fig. 3 and
Fig. S2), except for A/Taiwan/2885/2008, whose M gene fell into
clade 2 (Fig. 3B). The mismatch in these tree topologies strongly
suggested that the viruses of clade 2B were generated through a 4
(PB1, NP, NS and M)+4 (HA, NA, PB2, and PA) reassortment
between clade 1 and 2. The 8 segments of clades 2A and 2C were
consistently located at clade 2, indicating that reassortment has not
yet happened in these two clade viruses. In addition, the other two
kinds of reassortment were observed. The virus A/England/594/
2006 represented a 6+2 reassortment event between clade 1 and 2,
that is, its PB2, PA, PB1, NP, NS and M segments were located in
clade 1 and the HA and NA segments in clade 2 (Table 2). The
virus A/Taiwan/2885/2008 represented a 3+5 reassortment event
between clade 1 and 2. Its PB1, NP and NS segments were located
in clade 1 and HA, NA, PB2, PA and M segments in clade 2
(Table 2).
Amino acid substitutions associated with oseltamivir-
resistant seasonal influenza A/H1N1 viruses
To understand the genetic differences between the oseltamivir-
resistant and sensitive viruses, amino acid substitutions of
representative viruses in the same HA clade were compared. In
clade 2B-1, there was only one virus with H275Y, A/Taiwan/
3293/2008, identified before May 2008. It harbored only the
H275Y substitution in the NA and no specific substitution was
found by comparison with the wild-type clade 2B-1 viruses
(Table 3). Of note, the other four clade 2B-1 viruses with H275Y,
collected after October 2008 during the 2008–2009 epidemic, had
five additional amino acid substitutions located in three different
genome segments, including D354G in NA, L30R and H41P in
PB1-F2, and V411I and P453S in PB2 (Table 3). Among the clade
2B-2 viruses in the 2008–2009 season, all of them harbored these
five substitutions comparing to the wild-type clade 2B-1 viruses.
We also detected additional substitutions at positions 158, 200 and
202 in HA (H1 numbering, referred to A/New Caledonia/20/
1999 and the starting methionine counted as 1, used elsewhere in
this study) and position 642 in PB1 genes (Table 3), which likely
represented drift mutations and were associated less with the
spread of clade 2B-2 viruses. To investigate whether these
substitutions occurred in the global isolates, we analyzed
Oseltamivir-Resistant Influenza A/H1N1 Viruses
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e18177Figure 1. The frequency of the H275Y substitution in NA genes and monthly distribution of influenza isolates confirmed in Taiwan
from 2005 to 2009. (A) The NA genes of seasonal influenza A/H1N1 viruses isolated in Taiwan from 2005 to 2009 were sequenced and analyzed for
the mutation associated with oseltamivir resistance. The number of isolates tested and their H275Y ratio are illustrated by a black line and white bar,
respectively. The H275Y positivity rate rose quickly from 4.2% (2/47) before August to 100% (37/37) in December in 2008. (B) The number of influenza
isolates and their positivity rates. Seasonal influenza A/H1N1 viruses were the predominant circulating subtypes in the 2005–2006, 2007–2008 and
2008–2009 epidemics and the influenza B viruses were predominant in 2006–2007. The seasonal A/H3N2 viruses also co-circulated during these four
influenza seasons. Since July 2009, the pandemic H1N1 viruses started to replace the seasonal influenza viruses and became dominant. (C) The clade-
based epidemiological curves of the seasonal influenza A/H1N1 viruses. The 1585 isolates were classified into four distinct clades: 1, 2A, 2B (2B-1 and
2B-2) and 2C (2C-1 and 2C-2) according to the phylogenetic analyses and amino acid substitutions of HA sequences. The major viruses in 2005–2006,
2007–2008 and 2008–2009 seasons were clade 2A, 2B-1 and 2B-2, respectively. Minor species from other clades circulated during this period.
doi:10.1371/journal.pone.0018177.g001
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isolated worldwide during 2006 to 2009 with available full genome
sequences in the Influenza Virus Resource database (Fig. 4 and
Table S1). Amino acid substitutions differences especially those
between clade 2B-1 and 2B-2 were focused on and shown in Fig. 4.
The substitutions, A206T in HA, D354G in NA, N642S in PB1,
L30R and H41P in PB1-F2 and V411I and P453S in PB2 were
also highly correlated with the H275Y in NA genes. Therefore,
these widespread substitutions were observed in the viruses isolated
from Taiwan as well as the global. For clade 2C viruses, the only
one isolate with H275Y, A/Taiwan/2832/2008, was detected and
isolated in October 2008. This had not acquired any additional
substitution, compared to the wild-type clade 2C viruses (Table 3).
We also analyzed the S31N substitutions in M2, conferring
resistance to amantadine. Among the representative viruses, the
eight viruses in HA clades 1 and 2A have no S31N substitutions.
In clade 2B, only one isolate, A/Taiwan/2885/2008, was found to
carry the S31N substitution. This double resistance to amantadine
and oseltamivir resulted from the 3+5 reassortment of the virus
Table 1. H275Y substitution ratio of NA gene in different HA-
clade influenza A/H1N1 viruses in Taiwan during 2005–2009.
residue 275 of NA gene Clades (HA gene)
1 2A 2B-1 2B-2 2C-1 2C-2
H5 9 2 6 0 6 1 5
Y0 0 8 1 3 0 0 1
275Y ratio (%) 0 0 23.5 100 0 6.3
doi:10.1371/journal.pone.0018177.t001
Table 2. Characteristics of the 25 representative seasonal influenza A/H1N1 viruses analyzed in this study.
Virus name
Isolation
date (y/m/d) Clade classification in each phylogeny
Amino acid residue
(of the gene)
Oseltamivir
Carboxylate
IC
50 (nM)
HA NA PB2 PA PB1 NP M NS 275(NA) 31(M2)
A/Taiwan/5515/2005 2005/1/13 1 1 11111 1H S 1.02
A/Taiwan/5524/2005 2005/1/21 1 1 11111 1H S 0.54
A/Taiwan/10393/2005 2005/12/28 2A 2A 2A 2A 2A 2A 2A 2A H S 0.37
A/Taiwan/2900/2006 2006/1/13 2A 2A 2A 2A 2A 2A 2A 2A H S 0.73
A/Taiwan/5505/2006 2006/1/4 2A 2A 2A 2A 2A 2A 2A 2A H S 0.49
A/Taiwan/0586/2006 2006/2/14 2A 2A 2A 2A 2A 2A 2A 2A H S 0.86
A/Taiwan/192/2006 2006/6/30 2A 2A 2A 2A 2A 2A 2A 2A H S 1.15
A/Taiwan/2823/2008 2008/9/19 2A 2A 2A 2A 2A 2A 2A 2A H S 0.57
A/Taiwan/10092/2007 2007/11/14 2B 2B 2B 2B 1 1 1 1 H S 0.26
A/Taiwan/3293/2008 2008/5/2 2B 2B 2B 2B 1 1 1 1 Y S 280.2
A/Taiwan/0258/2008 2008/10/16 2B 2B 2B 2B 1 1 1 1 H S 0.36
A/Taiwan/10103/2008 2008/10/29 2B 2B 2B 2B 1 1 1 1 Y S 153.4
A/Taiwan/2885/2008 2008/11/24 2B 2B 2B 2B 1 1 2 1 Y N 177.3
A/Taiwan/11526/2008 2008/12/1 2B 2B 2B 2B 1 1 1 1 Y S 159.2
A/Taiwan/1026/2009 2009/1/13 2B 2B 2B 2B 1 1 1 1 Y S 156.5
A/Taiwan/9042/2008 2008/11/11 2B 2B 2B 2B 1 1 1 1 Y S 139.9
A/Taiwan/5857/2008 2008/12/8 2B 2B 2B 2B 1 1 1 1 Y S 347.9
A/Taiwan/5858/2008 2008/12/8 2B 2B 2B 2B 1 1 1 1 Y S 821.7
A/Taiwan/8949/2008 2008/12/11 2B 2B 2B 2B 1 1 1 1 Y S 471.3
A/Taiwan/0045/2006 2006/5/24 2 2 22222 2Y N 3 5 8 . 4
A/Taiwan/6566/2006 2006/7/4 2C 2C 2C 2C 2C 2C 2C 2C H N 0.63
A/Taiwan/3700/2007 2007/3/19 2C 2C 2C 2 2C 2C 2C 2C H N 0.55
A/Taiwan/2832/2008 2008/10/6 2C 2C 2C 2C 2C 2C 2C 2C Y N 711.5
A/Taiwan/6723/2008 2008/10/13 2C 2C 2C 2C 2C 2C 2C 2C H N 0.35
A/Taiwan/8885/2008 2008/10/27 2C 2C 2C 2C 2C 2C 2C 2C H N 0.36
A/New Caledonia/20/1999* 1999/6/9 -
# ------ -HSN D
A/Brisbane/59/2007* 2007/7/1 2B 2B 2B 2B 1 1 1 1 H S ND
A/England/494/2006* 2006/4/11 1 1 11111 1Y S N D
A/England/594/2006* 2006/3/31 2 2 11111 1Y S N D
A/Kansas/UR06-0104/2007* 2007/1/30 1 1 11111 1Y S N D
*: Viruses as the reference strains.
#: A/New Caledonia/20/1999 was employed as an outgroup root for the trees.
ND: not determined.
doi:10.1371/journal.pone.0018177.t002
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PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e18177Figure 2. Phylogenetic relationships of the HA and PB2 segments of influenza A/H1N1 viruses in Taiwan. The phylogenetic analyses
were constructed using the neighbor-joining method with 1000 bootstrap replications. Branch values of more than 75 are indicated. All of the
phylogenies were rooted with the A/New Caledonia/20/1999, which was the vaccine strain recommended by WHO during the 2001–2007 influenza
seasons. The genome sequences of A/Solomon Islands/3/2006, A/Brisbane/59/2007 and the early isolates carrying the H275Y substitution, A/England/
494/2006, A/England/594/2006 and A/Kansas/UR06-0104/2007 obtained from the NCBI database also were included. Different clades were shown by
different colors.
doi:10.1371/journal.pone.0018177.g002
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PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e18177Figure 3. Phylogenetic relationships of the PB1 and M segments of influenza A/H1N1 viruses in Taiwan. The phylogenetic analyses
were constructed using the neighbor-joining method with 1000 bootstrap replications. Branch values of more than 75 are indicated. All of the
phylogenies were rooted with the A/New Caledonia/20/1999. Different clades were shown by different colors.
doi:10.1371/journal.pone.0018177.g003
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the S31N substitution in M2 (Table 2).
Neuraminidase activity and quasi-species analysis of the
cultured seasonal influenza A/H1N1 viruses encoding
275H, 275Y in NA gene
The 50% inhibitory concentrations (IC50) for oseltamivir against
the 25 representative viruses were determined (Table 2). Among
them, the oseltamivir IC50 values of the 275Y encoding viruses
were in the range 139.9–821.7 nM, while the values of the 275H
ones were 0.26–1.15 nM. In addition, we examined the possibility
if the IC50-tested sensitive or resistant viruses contained quasi-
species of viral genotypes which were defined as components of
275H and 275Y populations in an oseltamivir-sensitive and
resistant virus, by cloning and sequencing the PCR-amplified viral
NA sequences. The sensitive virus, A/Taiwan/10092/2007,
showed all 275H type (100%, 50/50) and also the resistant virus,
A/Taiwan/3293/2008, showed all 275Y type (100%, 50/50),
indicating quasi-species genotypes were not detected in these two
viruses.
Discussion
In this study, we provided a comprehensive analysis of the
influenza A/H1N1 viruses collected in Taiwan during 2005–2009.
The combined data of influenza epidemic surveillance, oseltami-
vir-resistance testing and complete genetic analysis of the
circulating viruses during 2005–2009 revealed the evidence that
the annual epidemiological replacement of various influenza A/
H1N1 variants associated with emergence and spread of the
oseltamivir-resistant influenza A/H1N1 viruses. In the early 2007–
2008 influenza season, oseltamivir-resistant influenza A/H1N1
viruses were detected first in Europe (14%, 59/437), mainly in
Norway (70%, 26/37). The frequency of oseltamivir-resistant
viruses in Europe increased to 24.3% (727/2992) at the end of
2007–2008 influenza season. These viruses exhibited a NA H275Y
substitution (N1 numbering), conferring resistance to oseltamivir
and emerged without antiviral pressure [3,7,22,24]. During April
to September in 2008, the high frequency of H275Y substitution
was detected in South Africa (225/225, 100%) and in Australia
(93%, 71/76). In the same period, the high frequency of H275Y
substitution has not yet been detected in Asia countries, including
Table 3. Amino acid substitutions of the representative isolates in different proteins.
Virus name
Clade
(HA) Amino acid substitutions in various proteins
HA NA PB1 PB1-F2 PB2 M2
158 200 202 206 194 222 234 275 354 642 30 41 411 453 31
A/New Caledonia/20/1999 - S N G A G R V H G N L H V P S
A/Taiwan/5515/2005 1 S N G A G R V H G N L H V H S
A/Taiwan/5524/2005 1 S N G A G R V H G N L H V H S
A/Taiwan/10393/2005 2A S N G A G R M H G N L H V P S
A/Taiwan/2900/2006 2A S N G A G R M H G N L H V P S
A/Taiwan/5505/2006 2A S N G A G R M H G N L H V P S
A/Taiwan/0586/2006 2A S N G A G R M H G N L H V P S
A/Taiwan/192/2006 2A S N G A G R M H G N L H V P S
A/Taiwan/2823/2008 2A S N G A G R M H G N L H V P S
A/Brisbane/59/2007 2B-1 S N G A G Q M H D N L H V P S
A/Taiwan/10092/2007 2B-1 S N G A G Q M H D N L H V P S
A/Taiwan/3293/2008 2B-1 S N G A G Q M Y D N L H V P S
A/Taiwan/0258/2008 2B-1 S N G A G Q M H D N L H V P S
A/Taiwan/10103/2008 2B-1 S N G A G Q M Y G N R P I S S
A/Taiwan/2885/2008 2B-1 S N G A G Q M Y G N R P I S N
A/Taiwan/11526/2008 2B-1 S N G A G Q M Y G N R P I S S
A/Taiwan/1026/2009 2B-1 S N G A G Q M Y G N R P I S S
A/Taiwan/9042/2008 2B-2 N N A T G Q M Y G S R P I S S
A/Taiwan/5857/2008 2B-2 S S S T G Q M Y G N R P I S S
A/Taiwan/5858/2008 2B-2 S S S T G Q M Y G N R P I S S
A/Taiwan/8949/2008 2B-2 N N A T G Q M Y G S R P I S S
A/Taiwan/0045/2006 2 S N G A G Q M Y G N L H V P N
A/Taiwan/6566/2006 2C-1 S N G T G Q M H G N L H V P N
A/Taiwan/3700/2007 2C-1 S N G T G Q M H G N L H V P N
A/Taiwan/2832/2008 2C-2 S N G T G Q M Y G N L H V P N
A/Taiwan/6723/2008 2C-2 S N G T G Q M H G N L H V P N
A/Taiwan/8885/2008 2C-2 S N G T G Q M H G N L H V P N
doi:10.1371/journal.pone.0018177.t003
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2/17) (in this study and [24]). In Japan, the ratio of resistant
viruses increased from 0.4% (3/687) in the 2007–2008 season to
100% (745/745) in the 2008–2009 season [25]. In Americas, the
frequencies of oseltamivir resistant influenza A/H1N1 viruses
increased from 10.9% (111/1020, October 2007–May 2008) to
99.2% (649/654, October 2008–March 2009) in the United States
of America (http://www.cdc.gov/flu/weekly/pastreports.htm).
The global frequency of resistant viruses increased from 44%
(April 2008–September 2008) to 96% (October 2008–March
2009) [9,24]. Based on the tempo-spatial global distribution of
oseltamivir-resistant influenza A/H1N1 viruses, spread trend of
there resistant viruses seemed to start from Europe and migrated
to the southern hemisphere, followed by North America and Asia.
The emergence and fast global spread highlight the importance of
continuation of antiviral resistant surveillance and timely global
response.
Genome segment reassortment contributes to the increase of
influenza diversity and is associated with severe epidemics and
disaster pandemics. Influenza A viruses caused four human
influenza pandemics in 1918 (H1N1 subtype), 1957 (H2N2
subtype), 1968 (H3N2 subtype) and 2009 (H1N1 subtype), and
those viruses all emerged through complex inter-subtype reassort-
ment events [26,27]. Furthermore, intra-subtype reassortments as
well as antigenic drift have been demonstrated to be an important
process in the evolution and annual epidemics of human influenza
A/H1N1 viruses and were responsible for several notable
epidemics of unusual severity in the 1940s and 1950s [28]. In
this study, we investigated the evolutionary histories and
epidemiology of seasonal influenza A/H1N1 viruses in Taiwan.
During 2005–2009, there were four influenza epidemics in
Taiwan and three of the four were caused by the H1N1 subtype
and predominated by different variants, including HA clades 2A,
2B-1 and 2B-2, respectively (Fig. 1C). The epidemic variant
turnover from clade 2A to 2B-1 during 2005–2007 was due to the
effect of the intra-subtype reassortment and drift mutations
(Table 2 and 3). The following two successive influenza epidemics
of 2007–2008 and 2008–2009 in Taiwan were predominated by
variant clades 2B-1 and 2B-2, respectively, and they were
antigenically relative to A/Brisbane/59/2007, the influenza A/
H1N1 component of the 2008–2009 and 2009–2010 influenza
vaccine for the Northern Hemisphere (data not shown and [29]).
These two variants had similar genetic segments and differed by
major mutations located in HA, NA, PB1, PB1-F2 and PB2
(Table 3). In addition, the non-reassortant clade 2C viruses, which
could not become dominant and spread widely like clade 2B
viruses, were also coexisting and circulating continually at low
activity during 2005–2009 in Taiwan. These results strongly
highlighted the importance of genome segment reassortment and
drift mutations of surface and internal genes in the predominance
and annual epidemic recurrence of influenza viruses.
Worldwide spread of antiviral-resistant influenza viruses has been
observed for subtypes H3N2 and H1N1. Genomic reassortment and
additional substitutions also have been considered as important in the
evolutionary processes of emergence and spread of adamantane-
resistant influenza A/H3N2 viruses in 2005–2006 and a hitch-hiking
mechanism was used to explain the occurrence of the S31N
substitution in M2 protein of this particular variant [14]. In this
study, we observed that the worldwide spread of oseltamivir-resistant
influenza A/H1N1 viruses during 2007–2009 were generated by
reassortment and drift mutations, and the H275Y in the NA protein
also seemed to spread in a hitch-hiking mechanism. We analyzed the
phylogenetic trees of the four early oseltamivir-resistant viruses
collected before January 2007 and the representative viruses isolated
in Taiwan during 2005–2009. The resultant phylogenies revealed that
each segment of A/Taiwan/0045/2006 was closely related to clade
2C and those of A/England/494/2006 and A/Kansas/UR06-0104/
2007 were located in clade 1 (Table 2). Of note, the clade 2B-related
A/England/594/2006, whose PB2 and PA genes still fell into clade 1,
represented another reassortment event-a 6+2 pattern between clade
1 and 2 (Table 2). The data suggested that the resistant viruses prior to
2007 occurred sporadically in clade 1 and clade 2, and new variants
Figure 4. Amino acid changes in various proteins between clades 2B-1 and 2B-2 in the 92 global isolates. Amino acids substitutions at
positions 158, 200, 202, 206 in HA, 275, 354 in NA, 642 in PB1, 30, 41 in PB1-F2, and 411, 453 in PB2 are represent by various colors. Each column
represents the amino acid position indicated. Amino acids (single-letter abbreviations are used) are indicated by different colors, as shown in the key.
Each row represents a single isolate and the 92 isolates analyzed are displayed in this figure in the order of collection time. The 92 isolate names are
listed in Table S1.
doi:10.1371/journal.pone.0018177.g004
Oseltamivir-Resistant Influenza A/H1N1 Viruses
PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e18177(clade 2B) were generated through intra-subtype reassortment events
between these two clades stepwise (6+2t o4 +4) during 2006–2007 and
acquired additional substitutions in the evolutionary processes. During
the epidemic turnover of dominant variants from clade 2B-1 to 2B-2
viruses within the two influenza seasons of 2007–2008 and 2008–2009
in Taiwan, several major substitutions were detected without genomic
reassortment, including A206T in HA, H275Y and D354G in NA,
N642S in PB1, L30R and H41P in PB1-F2 and V411I and P453S in
PB2 (Table 3). Some of there substitutions should enhance the viral
fitness and contribute to epidemic recurrence. In the previous studies,
the residue 354 in NA protein was found to locate at the top of the
neuraminidase tetramer, the residue 206 was the receptor binding
domain of the HA1 protein and the residue 453 was the nuclear
localization signal of the PB2 [20,30,31]. However, the roles of these
substitutions on influenza epidemiology remain to be studied. It was
worth mentioning that these substitutions were not observed in
oseltamivir-resistant clade 2C viruses, except for A206T in HA and
D354G in NA.These results revealed that the H275Y NA substitution
occurred coincidentally with the advantageous substitutions and
hitchhiked with a dominant variant during the evolution processes,
resulting in the widespread resistant viruses.
Some substitutions R194G, V234M and R222Q of NA proteins
were involved in buffering deficiencies on folding or stability of
neuraminidase caused by the H275Y substitution and restore viral
fitness [32]. In this study, all of 25 viruses in HA clades 1, 2A, 2B
and 2C harbored the R194G substitution, and the viruses of the last
three clades also carried the V234M substitution. For the R222Q
substitution, the clade 2B and 2C viruses have acquired this
substitution (Table 3). Overall, both clade 2B and 2C viruses have
acquired sufficient changes to overcome the obstacles caused by
H275Y. However, the clade 2C viruses were still not observed to
spread widely like clade 2B viruses, indicating that these
substitutions, buffering deficiencies induced by the H275Y
substitution, were required but not enough for the widespread
oseltamivir-resistant viruses. It was suggested that when a suitable
genetic background was established through reassortment and
mutations, the resistance-conferring mutation H275Y in the NA
gene could hitch-hike with other compensating mutations elsewhere
in the genome to make a dominant oseltamivir-resistant virus
spread. In addition, since the double resistant viruses from various
clade 2B and 2C viruses have been found in Taiwan, and also
detected inHongKong [33,34], the possibility forworldwidespread
of multiple antiviral-resistant viruses should be concerned.
Materials and Methods
Collection of specimens, viral isolates, viral RNA
extraction, and the medication of patients
This study was conducted through the national influenza
surveillance network in Taiwan, which is coordinated by the
Centers for Disease Control (CDC), Department of Health,
Taiwan. This surveillance points cover approximately 75% of
basic administrative units of Taiwan (cities, townships or districts)
[35]. More than ten virology laboratories in Taiwan routinely
collected clinical specimens throughout year and isolated viruses
by using Madin Darby canine kidney (MDCK) cells and identified
subtypes by immunofluorescence assay (IFA). Then, these isolates
were sent to CDC, Taiwan for further analysis. Viral RNA was
extracted from the supernatant of cultured viral isolates using
QIAamp Viral RNA Mini Kits, according to the manufacturer’s
instructions (Qiagen, Santa Clara, CA). Automated extraction also
was conducted using the MagNa Pure LC extraction system
(Roche). For the medication of the patients with influenza-like
illness, oseltamivir was rarely prescribed in Taiwan before May
2009 (the outbreak of 2009 pandemic H1N1). We believed that
the analyzed viruses in this study were isolated from patients
without oseltamivir-treatment, although we did not have their
clinical record of drug therapy.
Epidemic curve of various clade influenza A/H1N1
variants confirmed in Taiwan from 2005 to 2009
The partial HA sequences of the influenza viruses from 2005–
2009 were determined by conventional RT-PCR and sequencer
(ABI 3730). Based on phylogenetic analyses and amino acid
substitutions of analyzed sequences, we classified these seasonal
influenza A/H1N1 isolates into four distinct HA clades: 1, 2A, 2B
and 2C, which were designated by a previous study [29]. The
signature amino acids changes from clade 1 to 2 included T99K,
K225R, F269Y and T283N of the HA gene (H1 numbering,
referred to A/New Caledonia/20/1999 and the starting methio-
nine counted as 1, used elsewhere in this study). For the clade 2,
the key substitutions of clade 2B were D52N, K157E, R205K and
E290K, and those for clade 2C were D53N, R205M and A206T.
Clade 2B could be classified further into subclades 2B-1 and 2B-2,
based on the additional substitution of A206T, specific for clade
2B-2, and also, clade 2C into 2C-1 and 2C-2 by additional
substitutions I64K and E85G, carried by clade 2C-2 viruses.
Antiviral resistance and complete sequence analysis of
the seasonal influenza A/H1N1 viruses
Virus isolates identified as influenza A/H1N1viruses were tested
for oseltamivir resistance by analysis of NA sequences through a
conventional PCR. A 907 base-pair DNA fragment spanning
nucleotide position 823–825 (amino acid position 275, N1 number-
ing)ofNAgene wasamplified and thenucleotidesequencesalso were
determined. Isolates with a C to T substitution at nucleotide position
823 that could resultin the substitution of histidine (encoded by CAC)
for tyrosine (encoded by TAC) at amino acid position 275 in the NA
protein were identified as oseltamivir resistant. To focus in more
detail on the genetic diversity and phylogenetic histories of the
oseltamivir-resistant seasonal influenza A/H1N1 viruses during
2005–2009 in Taiwan, 25 representative isolates belonging to various
HA clades, 1, 2A, 2B and 2C, which were classified based on the HA
sequences and designated according to a previous study [29], were
selected for complete genome sequencing. The basic information for
the 25 isolates is shown in Table 2. The three oseltamivir-resistant
influenza A/H1N1 viruses, A/England/494/2006, A/England/
594/2006 and A/Kansas/UR06-0104/2007, isolated before the
2006–2007 influenza season and with complete genomic sequences
available from the NCBI influenza virus sequence database [36], also
were included in the study as reference sequences of oseltamivir-
resistant viruses in the early stage. Multiple sequence alignments,
protein translation and phylogenetic analysis were performed on the
basis of nucleotide sequences using the software MEGA4 [37] and
BioEdit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). A phy-
logenetic tree was constructed by the neighbor-joining method and
1,000 bootstrap replications were performed to evaluate the
robustness. The vaccine strains A/New Caledonia/20/1999 and
A/Brisbane/59/2007 also were included in the eight phylogenies as
reference sequences.
NA inhibition assay of the cultured influenza A/H1N1
virus
The 50% inhibitory concentration (IC50) analysis of oseltamivir for
influenza A/H1N1 viruses was determined using the NA-Star
Influenza Neuraminidase Inhibitor resistance Detection Kit (Applied
Biosystems) according to the manufacturer’s recommendations.
Oseltamivir-Resistant Influenza A/H1N1 Viruses
PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e18177Briefly, 25 ml of half-log dilutions of neuraminidase inhibitor (NI)
from 0.03 to 1000 nM were mixed with 25 ml of virus dilution with
equal amount viruses of 16 hemagglutination (HA) unit in each well
of a white 96-well microplate and incubated 10–20 min at 37uC.
Two wells of the mixture destined to be negative controls contained
only assay buffers, instead of NI, and culture medium, instead of
viruses, also were included. Then, 10 ml of diluted substrate was
added to each well and incubated for 10–30 min at room
temperature, followed by the addition of 60 ml of accelerator, the
chemiluminescent signal being measured immediately. The software
GraphPad Prism version 4.00 was used to determine the IC50 values.
Sequences information
The nucleotide sequences of influenza viruses in this study have
been submitted to GenBank and their accession numbers are
HQ291845-HQ292044.
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Figure S1 Phylogenetic relationships of the NA and PA
segments of influenza A/H1N1 viruses in Taiwan. The
phylogenetic analyses were constructed using the neighbor-joining
method with 1000 bootstrap replications.Branchvaluesofmorethan
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